Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2003 1
2009 1
2010 1
2011 1
2012 1
2013 2
2014 1
2015 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Digestive System Neuroendocrine Neoplasm"
Page 1
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.
Citterio D, Coppa J, Sposito C, Busset MDD, Virdis M, Pezzoli I, Mazzaferro V. Citterio D, et al. Curr Treat Options Oncol. 2023 Nov;24(11):1651-1665. doi: 10.1007/s11864-023-01124-w. Epub 2023 Oct 26. Curr Treat Options Oncol. 2023. PMID: 37882889 Free PMC article. Review.
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver, to improve prognosis and quality of life in cancer patients. In unresectable, liver-only metastases from neuroendocrine tumors (NETs) of …
Transplant oncology is a new field of medicine referred to the use of solid organ transplantation, particularly the liver, to improve progno …
Severe gastrointestinal toxicity of MEK inhibitors.
Mourad N, Lourenço N, Delyon J, Eftekhari P, Bertheau P, Allayous C, Ballon A, Pagès C, Allez M, Lebbé C, Baroudjian B; PATIO group. Mourad N, et al. Melanoma Res. 2019 Oct;29(5):556-559. doi: 10.1097/CMR.0000000000000618. Melanoma Res. 2019. PMID: 31095035
We performed a retrospective analysis of all patients with stage IV and unresectable stage III melanoma treated with a MEK inhibitors at Saint-Louis Hospital, Paris, between 1 August 2013 and 15 October 2018. Among 119 patients exposed to MEK inhibitors, 78 were treated wi …
We performed a retrospective analysis of all patients with stage IV and unresectable stage III melanoma treated with a MEK inhibitors …
Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases.
Kim HS, Shaib WL, Zhang C, Nagaraju GP, Wu C, Alese OB, Chen Z, Brutcher E, Renfroe M, El-Rayes BF. Kim HS, et al. Cancer. 2018 May 1;124(9):1992-2000. doi: 10.1002/cncr.31192. Epub 2018 Feb 16. Cancer. 2018. PMID: 29451701 Free article. Clinical Trial.
BACKGROUND: Neuroendocrine tumors (NETs) metastasize to the liver. Everolimus and selective internal radioembolization (SIRT) are approved treatments. ...Clinically significant liver toxicity was not observed. One patient had liver progression. QOL improved o …
BACKGROUND: Neuroendocrine tumors (NETs) metastasize to the liver. Everolimus and selective internal radioembolization (SIRT) …
The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors.
Meirovitz A, Shouchane-Blum K, Maly A, Bersudski E, Hirshoren N, Abrams R, Popovtzer A, Orevi M, Weinberger J. Meirovitz A, et al. J Cancer Res Clin Oncol. 2021 May;147(5):1335-1340. doi: 10.1007/s00432-021-03538-1. Epub 2021 Feb 17. J Cancer Res Clin Oncol. 2021. PMID: 33598797
BACKGROUND: Treatment regimens for patients with metastatic or recurrent post-radiation, locoregional, unresectable salivary cancer are limited. An inverse correlation between somatostatin receptor 2 (SSTR2) and the proliferating marker Ki-67 in neuroendocrine tu …
BACKGROUND: Treatment regimens for patients with metastatic or recurrent post-radiation, locoregional, unresectable salivary cancer a …
Tumor diagnosis in the adult liver transplant candidate.
Mahfouz A, Vogl T, Hamm B. Mahfouz A, et al. Eur Radiol. 1999;9(5):841-52. doi: 10.1007/s003300050754. Eur Radiol. 1999. PMID: 10369978 Review.
Hepatic transplantation has emerged as a potentially curative treatment of certain malignant hepatic neoplasms such as hepatocellular carcinoma, bile duct carcinoma, fibrolamellar hepatocellular carcinoma, metastases from neuroendocrine tumors, and epithelioid heman …
Hepatic transplantation has emerged as a potentially curative treatment of certain malignant hepatic neoplasms such as hepatocellular carcin …
Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Paprottka PM, Hoffmann RT, Haug A, Sommer WH, Raessler F, Trumm CG, Schmidt GP, Ashoori N, Reiser MF, Jakobs TF. Paprottka PM, et al. Cardiovasc Intervent Radiol. 2012 Apr;35(2):334-42. doi: 10.1007/s00270-011-0248-1. Epub 2011 Aug 17. Cardiovasc Intervent Radiol. 2012. PMID: 21847708
PURPOSE: To evaluate safety, efficacy, and symptom-control of radioembolization in patients with unresectable liver metastases from neuroendocrine tumors (NETLMs). MATERIALS AND METHODS: Forty-two patients (mean age of 62 years) with treatment-refractory NETL …
PURPOSE: To evaluate safety, efficacy, and symptom-control of radioembolization in patients with unresectable liver metastases from …
Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature.
Grossman EJ, Millis JM. Grossman EJ, et al. Liver Transpl. 2010 Aug;16(8):930-42. doi: 10.1002/lt.22106. Liver Transpl. 2010. PMID: 20677284 Free article. Review.
As additional data are accrued, OLT with neoadjuvant chemoradiation may become a viable alternative to resection for patients with localized, node-negative hilar CCA. Hepatic involvement from neuroendocrine tumors can be treated with OLT when metastases are unres …
As additional data are accrued, OLT with neoadjuvant chemoradiation may become a viable alternative to resection for patients with localized …
The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.
Bohlok A, Lucidi V, Bouazza F, Daher A, Germanova D, Van Laethem JL, Hendlisz A, Donckier V. Bohlok A, et al. World J Surg Oncol. 2020 May 25;18(1):106. doi: 10.1186/s12957-020-01883-y. World J Surg Oncol. 2020. PMID: 32450872 Free PMC article.
BACKGROUND: The benefit of surgery in patients with non-colorectal non-neuroendocrine liver metastases (NCRNNELM) remains controversial. At the population level, several statistical prognostic factors and scores have been proposed but inconsistently verified. ...Neg …
BACKGROUND: The benefit of surgery in patients with non-colorectal non-neuroendocrine liver metastases (NCRNNELM) remains controversi …
Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
Agarwala SS, Eggermont AM, O'Day S, Zager JS. Agarwala SS, et al. Cancer. 2014 Mar 15;120(6):781-9. doi: 10.1002/cncr.28480. Epub 2013 Dec 2. Cancer. 2014. PMID: 24301420 Free article. Review.
HIA and intravenous delivery of fotemustine have been compared in a randomized phase 3 trial in patients with unresectable metastases from melanoma, but no differences between the 2 approaches were observed. ...For patients with unresectable ocular melanoma, …
HIA and intravenous delivery of fotemustine have been compared in a randomized phase 3 trial in patients with unresectable metastases …
Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors.
Bertani E, Zugni F, Radice D, Spada F, Bonomo G, Fumagalli Romario U, Fazio N, Funicelli L. Bertani E, et al. Updates Surg. 2022 Oct;74(5):1697-1704. doi: 10.1007/s13304-022-01251-3. Epub 2022 Feb 27. Updates Surg. 2022. PMID: 35224681
BACKGROUND: Vascular infiltration may jeopardize resection of the primary tumor and mesenteric metastatic masses in small-intestine neuroendocrine tumors (SI-NETs). However, other factors may play a role in predicting resectability. ...CONCLUSIONS: SMA stage …
BACKGROUND: Vascular infiltration may jeopardize resection of the primary tumor and mesenteric metastatic masses in small-intestine neuro …
16 results